Overview
MioDottore operates as Italy’s leading platform that connects patients with doctors, clinics, and hospitals in both private and public sectors. By using its website, patients can browse providers and book medical visits with the most suitable doctor or facility, while clinics and hospitals use the platform to manage patient flow and boost their online presence. The service leverages a nationwide network and is integrated with Docplanner’s international Health Tech ecosystem, enabling providers to reach more patients and streamline scheduling. The company’s goal is to help people live longer, healthier lives by making high-quality medical care easier to access and faster to arrange through technology.
Work here?Claim your company
Simplify's take
What believers are saying
- November 2026: Docplanner raised €80 million, signaling investor support and acquisition capacity.
- Twilio case study says Noa Booking doubled bookings and cut call-center costs 50%.
- November 2026: MioDottore opened Naples hiring, showing sales expansion instead of contraction.
What critics are saying
- Doctolib still outranks MioDottore on integrated practice software across France, Germany, and Italy.
- November 2026: Docplanner's €80 million raise funds hiring, acquisitions, and faster product warfare.
- AI booking commoditizes scheduling; if Noa underperforms, doctors can switch within one renewal cycle.
What makes MioDottore unique
- November 2026: Docplanner paired MioDottore bookings with Noa Notes, Noa Booking, and Noa Evidence.
- MioDottore owns patient demand, doctor reviews, and appointment workflows in one Italian platform.
- June 2026: MioDottore Awards strengthen physician loyalty and brand gravity across 43 specialties.
Help us improve and share your feedback! Did you find this helpful?